BRAND NAME:

Constipas

GENERIC NAME:

Prucalopride

THERAPEUTIC SEGMENT:

Gastrointestinal Prokinetic Agent

INDICATIONS:

Constipas is indicated for the treatment of chronic idiopathic constipation (CIC) in adults.

BRIEF DESCRIPTION:

Prucalopride is an orally bioavailable, selective serotonin 5-HT₄ receptor agonist that stimulates colonic motility by enhancing peristalsis and accelerating intestinal transit. It acts directly on the enteric nervous system, promoting coordinated muscle contractions essential for effective bowel movements. Unlike traditional laxatives, Prucalopride targets impaired motility rather than altering stool consistency, making it effective for the treatment of chronic idiopathic constipation (CIC).

DOSAGE FORM:

Tablets

1mg

2mg